Patterson Companies, Silk Road Medical, Micron, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were slightly higher, with the Dow Jones index gaining around 0.1% on Tuesday. Shares of Patterson…
Intra-Cellular Therapies’ Highlights Successful Data From Second Depression Study
Intra-Cellular Therapies reports positive topline results for Study 502 on lumateperone 42 mg as adjunctive therapy for major depressive disorder. FDA application expected in H2 2024.
Where Intra-Cellular Therapies Stands With Analysts
Across the recent three months, 14 analysts have shared their insights on Intra-Cellular Therapies (NASDAQ:ITCI), expressing a variety…
Analyst Ratings For Intra-Cellular Therapies
Throughout the last three months, 18 analysts have evaluated Intra-Cellular Therapies (NASDAQ:ITCI), offering a diverse set of opinions…
The Analyst Verdict: Intra-Cellular Therapies In The Eyes Of 14 Experts
Providing a diverse range of perspectives from bullish to bearish, 14 analysts have published ratings on Intra-Cellular Therapies…
How Is The Market Feeling About Intra-Cellular Therapies?
Intra-Cellular Therapies’s (NYSE:ITCI) short percent of float has risen 4.8% since its last report. The company recently reported…
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Intra-Cellular Therapies Announces $500M Proposed Public Offering Of Common Stock
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) ("Intra-Cellular Therapies"), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Palisade Bio (NASDAQ:PALI) stock increased by 65.1% to $6.87 during Tuesday’s regular session. The company’s market cap…